Autonomix Medical Inc (NASDAQ:AMIX), Stock Drops -96.55% Far This Year; What Analysts Say Next?

In recent trading session, Autonomix Medical Inc (NASDAQ:AMIX) saw 2.99 million shares changing hands at last check today with its beta currently measuring -3.37. Company’s recent per share price level of $1.84 trading at $0.1 or 5.75% at last check today assigns it a market valuation of $4.54M. That most recent trading price of AMIX’s stock is at a discount of -2943.48% from its 52-week high price of $56.00 and is indicating a premium of 17.39% from its 52-week low price of $1.52. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 70730.0 shares which gives us an average trading volume of 75.65K if we extend that period to 3-months.

Autonomix Medical Inc (NASDAQ:AMIX) trade information

Upright in the green today for gaining 5.75%, in the last five days AMIX remained trading in the green while hitting it’s week-highest on Tuesday, 05/13/25 when the stock touched $1.84 price level, adding 3.16% to its value on the day. Autonomix Medical Inc’s shares saw a change of -51.06% in year-to-date performance and have moved 8.24% in past 5-day. Autonomix Medical Inc (NASDAQ:AMIX) showed a performance of 10.18% in past 30-days. Number of shares sold short was 0.18 million shares which calculate 1.44 days to cover the short interests.

In 2025, company’s earnings growth rate is likely to be around 60.65% while estimates for its earnings growth in next 5 years are of 28.36%.

Autonomix Medical Inc (NASDAQ:AMIX)’s Major holders

Insiders are in possession of 19.52% of company’s total shares while institution are holding 18.89 percent of that, with stock having share float percentage of 23.47%. Investors also watch the number of corporate investors in a company very closely, which is 18.89% institutions for Autonomix Medical Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and iShares Trust-iShares Micro-Cap ETF are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 6.76 shares of worth $12303.0 or 0.27% of the total outstanding shares. The later fund manager was in possession of 1.58 shares on Mar 31, 2025 , making its stake of worth around $2871.0 in the company or a holder of 0.06% of company’s stock.